Log in to save to my catalogue

P2.012 Clinical Care Pathways Using Chlamydia and Gonorrhoea Tests Are Evolving: Point of Care Nucle...

P2.012 Clinical Care Pathways Using Chlamydia and Gonorrhoea Tests Are Evolving: Point of Care Nucle...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1781696965

P2.012 Clinical Care Pathways Using Chlamydia and Gonorrhoea Tests Are Evolving: Point of Care Nucleic Acid Amplification Tests May Reduce Genitourinary Medicine Service Delivery Costs

About this item

Full title

P2.012 Clinical Care Pathways Using Chlamydia and Gonorrhoea Tests Are Evolving: Point of Care Nucleic Acid Amplification Tests May Reduce Genitourinary Medicine Service Delivery Costs

Publisher

London: BMJ Publishing Group Ltd

Journal title

Sexually transmitted infections, 2013-07, Vol.89 (Suppl 1), p.A91-A91

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

Background We aimed to explore new patient pathways using a chlamydia/gonorrhoea (CT/NG) point of care nucleic acid amplification tests (POC NAAT), and estimate and compare the costs of the new pathways to the current pathways using standard laboratory-based NAAT testing. Methods A qualitative and quantitative approach was used. Focus groups were c...

Alternative Titles

Full title

P2.012 Clinical Care Pathways Using Chlamydia and Gonorrhoea Tests Are Evolving: Point of Care Nucleic Acid Amplification Tests May Reduce Genitourinary Medicine Service Delivery Costs

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1781696965

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1781696965

Other Identifiers

ISSN

1368-4973

E-ISSN

1472-3263

DOI

10.1136/sextrans-2013-051184.0277

How to access this item